Clinical Trials Logo

Mitral Regurgitation Functional clinical trials

View clinical trials related to Mitral Regurgitation Functional.

Filter by:
  • None
  • Page 1

NCT ID: NCT05846412 Not yet recruiting - Atrial Fibrillation Clinical Trials

Treatment of Functional Mitral Regurgitation in Patients With Atrial Fibrillation

CAMERA-Pilot
Start date: June 1, 2023
Phase: N/A
Study type: Interventional

The objective of the CAMERA-Pilot trial is to generate a hypothesis for a proper randomized controlled clinical endpoint trial to show the noninferiority of restoration and maintenance of sinus rhythm (via catheter ablation [CA] of AF) vs. mitral transcatheter edge-to-edge repair (M-TEER) in patients with AF and concomitant FMR. Patients will be stratified into ventricular FMR with atrial component and atrial FMR.

NCT ID: NCT04733404 Recruiting - Clinical trials for Mitral Regurgitation Functional

Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation

Start date: March 12, 2022
Phase: N/A
Study type: Interventional

To confirm the effectiveness and safety of the Dragonfly transcatheter mitral valve repair system for the treatment of chronic moderate to severe (3+) or severe (4+) functional mitral regurgitation (FMR) who remained clinically symptomatic after guideline-directed medical treatment.

NCT ID: NCT04399499 Recruiting - Clinical trials for Mitral Regurgitation Functional

Percutaneous Mitral Valve Repair in Cardiogenic Shock: Mitra-Shock Study

MSS
Start date: June 2020
Phase:
Study type: Observational

Cardiogenic shock (CS) is a medical emergency and a frequent cause of death. CS can be complicated and/or precipitated by mitral regurgitation (MR). The efficacy of percutaneous treatment of MR in patients with cardiogenic shock is unknown. The aims of the study will be to analyse the efficacy of MitraClip therapy on early (30 days) and midterm mortality (6 months) as well as the predictors of outcomes. Investigators will also report the rate of periprocedural complications such as minor and major bleeding, vessel injury and Acute Kidney Injury (AKI). It is a multicenter retrospective observational study on CE marked medical device (MitraClip® System). Retrospective time range: from 01/01/2012 to 01/01/2020

NCT ID: NCT04147884 Active, not recruiting - Clinical trials for Cardiovascular Diseases

A Feasibility Study of the Millipede Transcatheter Annuloplasty Ring System in Patients With Functional Mitral Regurgitation

Start date: November 13, 2019
Phase: N/A
Study type: Interventional

To evaluate the feasibility and safety of the Millipede Transcatheter Annuloplasty Ring System in subjects with functional mitral regurgitation

NCT ID: NCT03503851 Withdrawn - Clinical trials for Mitral Regurgitation Functional

Noninferiority Trial of MitraClip Implantation Strategies: 1 Clip vs. 2 Clips in Patients With Functional Mitral Regurgitation

One-Plus-One
Start date: May 2018
Phase: N/A
Study type: Interventional

Implantation of the MitraClip has become the most frequently used percutaneous technique to treat significant (grade 3+ or 4+) mitral regurgitation (MR) in elderly patients deemed inoperable or at high surgical risk. In Europe, about two-thirds of patients treated with the MitraClip suffer from MR of functional origin secondary to ischemic or dilated cardiomyopathy. At present, there is debate among operators on whether stabilizing/supporting a single adequately implanted clip with a second clip is beneficial for patients with functional MR.